The four serotypes of dengue recognize the same putative receptors in Aedes aegypti midgut and Ae. albopictus cells

BMC Microbiology

Volumn 6, Issue , 2006, Pages

  Mercado Curiel, Ricardo F ^a   Esquinca Avilés, Héctor Armando ^a,d   Tovar, Rosalinda ^a   Díaz Badillo, Álvaro ^a,b   Camacho Nuez, Minerva ^c   Muñoz, María De Lourdes ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE LA CIUDAD DE MÉXICO   (Mexico)

^d UNIVERSIDAD AUTÓNOMA DE CHIAPAS   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; INSECT PROTEIN; PROTEIN R67; PROTEIN R80; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

AEDES AEGYPTI; AEDES ALBOPICTUS; AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; IMMUNOPRECIPITATION; NONHUMAN; PROTEIN BINDING; RECEPTOR BINDING; SEROTYPING; VIRUS INFECTION;

AEDES; ANIMALS; CARRIER PROTEINS; DENGUE VIRUS; DIGESTIVE SYSTEM; INSECT VECTORS; MOLECULAR WEIGHT; RECEPTORS, VIRUS; SEROTYPING;

AEDES AEGYPTI; DENGUE VIRUS; DENGUE VIRUS GROUP; FLAVIVIRUS;

EID: 33749673399     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-6-85     Document Type: Article

References (45)

1. WHO (World Health Organization): Dengue Haemorrhagic fever: early recognition, diagnosis and hospital management - an audiovisual guide for health care workers responding to outbreaks. Weekly Epidemiological Record 2006, 81(38):362-363.
2. DEGPI (Dirección General de Epidemiología de la Secretaría de Salud) 2004 Boletín Epidemiología [http://www.dgepi.salud.gob.mx/boletin/].
3. Halstead SB: Antibody, macrophages, dengue virus infection, shock, and hemorrhage a pathogenetic cascade. Rev Infect Dis 1989, 11(Suppl 4):S830-S839.
4. Littaua R, Kurane I, Ennis FA: Human IgG Fc receptor II mediates antibody-dependent enhancement of dengue virus infection. J Immunol 1990, 144(8):3183-3186.
5. Tu WC, Chen CC, Hou RF: Ultrastructural studies on the reproductive system of male A. aegypti (Diptera: Culicidae) infected with dengue 2 virus. J Medx Entomol 1998, 35(1):71-76.
6. Mukhopadhyay S, Kuhn RJ, Rossmann MG: A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 2005, 3(1):13-22.
7. Jindadamrongwech S, Smith DR: Virus Overlay Protein Binding Assay (VOPBA) reveals serotype specific heterogeneity of dengue virus binding proteins on HepG2 human liver cells. Intervirology 2004, 47(6):370-373.
8. Moreno-Altamirano MM, Sanchez-Garcia FJ, Muñoz ML: Non Fc receptor-mediated infection of human macrophages by dengue virus serotype 2. J Gen Virol 2002, 83(5):1123-1130.
9. Muñoz ML, Cisneros A, Cruz J, Das P, Tovar R, Ortega A: Putative dengue virus receptors from mosquito cells. FEMS Microbiol Lett 1998, 168(2):251-258.
10. Zhang W, Chipman PR, Corver J, Johnson PR, Zhang Y, Mukhopadhyay S, Baker TS, Strauss JH, Rossmann MG, Kuhn RJ: Visualization of membrane protein domains by cryo-electron microscopy of dengue virus. Nat Struct Biol 2003, 10(11):907-912.
11. Reyes-Del Valle J, Chavez-Salinas S, Medina F, Del Angel RM: Heat shock protein 90 and heat shock protein 70 are components of dengue virus receptor complex in human cells. J Virol 2005, 79(8):4557-4567.
12. Sakoonwatanyoo P, Boonsanay V, Smith DR: Growth and production of the dengue virus in C6/36 cells and identification of a laminin-binding protein as a candidate serotype 3 and 4 receptor protein. Intervirology 2006, 49(3):161-172.
13. Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM: Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med 1997, 3(8):866-871.
14. Chen YC, Wang SY, King CC: Bacterial lipopolysaccharide inhibits dengue virus infection of primary human monocytes/macrophages by blockade of virus entry via a CD14-dependent mechanism. J Virol 1999, 73(4):2650-2657.
15. Marianneau P, Megret F, Olivier R, Morens DM, Deubel V: Dengue 1 virus binding to human hepatoma HepG2 and simian Vero cell surfaces differs. J Gen Virol 1996, 77(10):2547-2554.
16. Navarro-Sanchez E, Altmeyer R, Amara A, Schwartz O, Fieschi F, Virelizier JL, Arenzana-Seisdedos F, Despres P: Dendritic-cell-specific ICAM3-grabbing non-integrin is essential for the productive infection of human dendritic cells by mosquito-cell-derived dengue viruses. EMBO Rep 2003, 4(7):723-728.
17. Tassaneetrithep B, Burgess TH, Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K, Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA: DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med 2003, 197(7):823-829.
18. Lozach PY, Burleigh L, Staropoli I, Navarro-Sanchez E, Harriague J, Virelizier JL, Rey FA, Despres P, Arenzana-Seisdedos F, Amara A: Dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN)-mediated enhancement of dengue virus infection is independent of DC-SIGN internalization signals. J Biol Chem 2005, 280(25):23698-23708.
19. Halstead SB, Heinz FX, Barrett AD, Roehrig JT: Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June Vienna, Austria. Vaccine 2005, 23(7):849-856.
20. Black WC 4th, Bennett KE, Gorrochotegui-Escalante N, Barillas-Mury CV, Fernandez-Salas I, Munoz ML, Farfan-Ale JA, Olson KE, Beaty BJ: Flavivirus susceptibility in Aedes aegypti. Arch Med Res 2002, 33(4):379-388.
21. Lourenco-de-Oliveira R, Vazeille M, de Filippis AM, Failloux AB: Aedes aegypti in Brazil: genetically differentiated populations with high susceptibility to dengue and yellow fever viruses. Trans R Soc Trop Med Hyg 2004, 98(1):43-54.
22. Bennett KE, Olson KE, Munoz ML, Fernandez-Salas I, Farfan-Ale JA, Higgs S, Black WC 4th, Beaty BJ: Variation in vector competence for dengue 2 virus among 24 collections of Aedes aegypti from Mexico and the United States. Am J Trop Med Hyg 2002, 67(1):85-92.
23. Bosio CF, Beaty BJ, Black WC 4th: Quantitative genetics of vector competence for dengue-2 virus in Aedes aegypti. Am J Trop Med Hyg 1998, 59(6):965-70.
24. Gubler DJ, Nalim S, Tan R, Saipan H, Sulianti Saroso J: Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am J Trop Med Hyg 1979, 28(6):1045-52.
25. Tabachnick WJ, Wallis GP, Aitken TH, Miller BR, Amato GD, Lorenz L, Powell JR, Beaty BJ: Oral infection of Aedes aegypti with yellow fever virus: geographic variation and genetic considerations. Am J Trop Med Hyg 1985, 34(6):1219-24.
26. Chen Y, Maguire T, Marks RM: Demonstration of binding of dengue virus envelope protein to target cells. J Virol 1996, 70(12):8765-8772.
27. Kaufman BM, Summers PL, Dubois DR, Eckels K: Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection. Am J Trop Med Hyg 1987, 36(2):427-434.
28. Pryor MJ, Azzola L, Wright PJ, Davidson AD: Histidine 39 in the dengue virus type 2 M protein has an important role in virus assemble. J Gen Virol 2004, 85(12):3627-3636.
29. Zieler H, Nawrocki JP, Shahabuddin M: Plasmodium gallinaceum ookinetes adhere specifically to the midgut epithelium of Aedes aegypti by interaction with a carbohydrate ligand. J Exp Biol 1999, 202(5):485-495.
30. Bielefeldt-Ohmann H: Analysis of antibody-independent binding of dengue viruses and dengue virus envelope protein to human myelomonocytic cells and B lymphocytes. Virus Res 1998, 57(1):63-79.
31. Bielefeldt-Ohmann H, Meyer M, Fitzpatrick DR, Mackenzie JS: Dengue virus binding to human leukocyte cell lines: receptor usage differs between cell types and virus strains. Virus Res 2001, 73(1):81-89.
32. Hilgard P, Stockert OR: Heparan sulfate proteoglycans initiate dengue virus infection of hepatocytes. Hepatology 2000, 32(5):1069-1077.
33. Yazi Mendoza M, Salas-Benito JS, Lanz-Mendoza H, Hernandez-Martinez S, del Angel RM: A putative receptor for dengue virus in mosquito tissues: localization of a 45-kDa glycoprotein. Am J Trop Med Hyg 2002, 67(1):76-84.
34. Thaisomboonsuk BK, Clayson ET, Pantuwatana S, Vaughn DW, Endy TP: Characterization of dengue-2 virus binding to surfaces of mammalian and insect cells. Am J Trop Med Hyg 2005, 72(4):375-383.
35. Ramasamy MS, Sands M, Kay BH, Fanning ID, Lawrence GW, Ramasamy R: Anti-mosquito antibodies reduce the susceptibility of Aedes aegypti to arbovirus infection. Med Vet Entomol 1990, 4(1):49-55.
36. Igarashi A: Isolation of a Singh's Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J Gen Virol 1978, 40(3):531-544.
37. Putnak R, Barvir DA, Burrous JM, Dubois DR, D'Andrea VM, Hoke CH, Sadoff JC, Eckels KH: Development of a purified, inactivated, dengue-2 virus vaccine prototype in Vero cells: immunogenicity and protection in mice and rhesus monkeys. J Infect Dis 1996, 174(6):1176-1184.
38. Polo S, Ketner G, Levis R, Falgout B: Infectious RNA transcripts from full-length dengue virus type 2 cDNA clones made in yeast. J Virol 1997, 71(7):5366-5374.
39. Morrison M: Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins. Methods Enzymol 1980, 70(A):214-220.
40. Eichholz A, Crane RK: Isolation of plasma membranes from intestinal brush borders. Methods Enzymol 1974, 31(A):123-134.
41. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 7(72):248-254.
42. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
43. Richardson J, Molina-Cruz A, Salazar MI, Black W 4th: Quantitative analysis of dengue-2 virus RNA during the extrinsic incubation period in individual Aedes aegypti. Am J Trop Med Hyg 2006, 74(1):132-141.
44. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci 1979, 76(9):4350-4354.
45. Metsikko MK, Rajaniemi HJ: Immunoprecipitation of the lutropin receptor. Loss of receptor molecules during down-regulation. Biochem J 1984, 224(2):467-471.